Sinofn Health
Sinofn Health
In the global nutraceutical market, understanding the distinction between Ubidecarenone (oxidized CoQ10) and Ubiquinol (reduced CoQ10) is paramount for brands aiming for clinical efficacy. Ubidecarenone is the traditional form, favored for its superior shelf stability and cost-effectiveness. In contrast, Ubiquinol is the active, reduced form that offers significantly higher bioavailability, particularly crucial for aging populations or individuals with absorption deficiencies.
Ubiquinol is pre-converted, allowing the body to bypass the metabolic conversion process from Ubidecarenone. Our factory utilizes proprietary nano-emulsification technology to maximize the stability of Ubiquinol, solving the industry-wide challenge of oxidative sensitivity.
While Ubidecarenone remains the workhorse for standard health supplements, our R&D focus has shifted to advanced encapsulation techniques that extend the shelf life of Ubiquinol by 24 months, meeting rigorous global stability standards.
Partnering with a specialized Chinese manufacturer provides access to high-purity, bio-fermented CoQ10 raw materials. We ensure strict batch traceability and compliance with international pharmacopeia standards.
As a leader in the Chinese nutraceutical landscape, SINOFN bridges the gap between raw scientific potential and market-ready products. Our advantages extend beyond simple manufacturing:
SINOFN Health Co., Ltd. represents the zenith of science-driven contract manufacturing. Founded in 2012 by Mrs. GuoHong Liu, our journey began with a singular mission: to democratize access to high-quality nutritional foods, specifically for conditions like Phenylketonuria (PKU). Today, we serve global partners by combining clinical-grade research with massive industrial capacity.
We measure success not just in revenue, but in lives improved through accessible science. Our Tianjin R&D center, in partnership with the Chinese Academy of Sciences, remains the backbone of our innovation.
With 71+ registered trademarks and 36 patents, we prioritize intellectual property. Our facility holds ISO22000, HACCP, and HALAL certifications, ensuring global market entry for your brand.
Medical Innovation Director, Ph.D from Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, Associate Researcher, CAS Postdoc. Expert in bioactive compound delivery systems and CoQ10 stabilization.
Formulation Director, Senior Scientist (Netherlands). Specializing in EU regulatory compliance and nutraceutical delivery technology.
We support both startups and large enterprises with tiered MOQs. Our pilot-scale prototyping allows for smaller, cost-effective initial runs for market testing.
We employ advanced lipid-based delivery systems and softgel micro-encapsulation to prevent oxidation and ensure peak absorption in the digestive tract.
Yes. Our medical innovation team can customize formulations, including the inclusion of synergistic nutrients (like Vitamin E or Omega-3s) to enhance the efficacy of your CoQ10 products.
